- Home
- WEAV vs VOR Comparison
WEAV vs VOR Comparison
Compare WEAV & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WEAV | VOR |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.7M | 562.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WEAV | VOR |
|---|---|---|
| Price | $5.54 | $15.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $11.00 | ★ $64.78 |
| AVG Volume (30 Days) | ★ 2.1M | 618.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.50 | 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $239,024,000.00 | N/A |
| Revenue This Year | $17.20 | N/A |
| Revenue Next Year | $13.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.99 | N/A |
| 52 Week Low | $4.85 | $0.13 |
| 52 Week High | $12.19 | $49.95 |
Technical Indicators
Market Signals| Indicator | WEAV | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 54.26 |
| Support Level | $4.85 | $11.27 |
| Resistance Level | $7.31 | $16.95 |
| Average True Range (ATR) | 0.34 | 1.17 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 61.67 | 54.16 |
Price Performance
Historical ComparisonAbout WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.